# Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland

European Parliament procedure 2023/0064(COD) (COD - Ordinary legislative procedure (ex-codecision procedure), 9th term, committee ENVI). Stage: Procedure completed. 9 committee amendments tabled by 2 Members between 2023-04-12 and 2023-04-12.

## What the amendments focus on

A legislative proposal on specific rules for medicinal products for human use intended for the market of Northern Ireland. Amendments address the prohibition on displaying certain safety features, except anti-tampering device measures, on the packaging of those products, their removal or covering, the role of the qualified person and record-keeping, authorisation of new and innovative products by United Kingdom competent authorities, and the conditions and written guarantees required.

## Most active Members on this file

| Member | Country | Group | Amendments | Markdown |
|---|---|---|---|---|
| Pascal CANFIN | France | RE | 5 | https://amendeu.com/md/meps/96711.md |
| Beatrice COVASSI | Italy | S&D | 4 | https://amendeu.com/md/meps/240478.md |

## Official source documents

- PE745.507: https://www.europarl.europa.eu/doceo/document/ENVI-AM-745507_EN.pdf

Full amendment texts, votes and exports: https://amendeu.com/dossiers/2023-0064-COD · machine-readable: https://amendeu.com/data/dossiers/2023-0064-COD.json

---

Source: AmendEU (amendeu.com), built from Parltrack (ODbL), European Parliament Open Data ((c) European Union) and official Parliament documents. Aggregates CC BY 4.0.
Data refreshed: 2026-07-27. Human-readable version: https://amendeu.com/dossiers/2023-0064-COD
When citing, attribute to "AmendEU (amendeu.com)".